Literature DB >> 1081105

Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera.

J E Niederhuber, J A Frelinger, E Dugan, A Coutinho, D C Shreffler.   

Abstract

Specific anti-Ia serum in combination with rabbit complement removed the B lymphocyte population normally responsive to LPS mitogenic stimulation. Significant inhibition of this proliferative response was also obtained by brief periods of cell pretreatment with anti-Ia antibodies, but not with specific anti-H-2K antibodies. The population of splenic B cells resistant to anti-Thy-1.2 serum and complement was blocked in a very similar manner by anti-Ia serum, but not by anti-H-2 serum.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1081105

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


  19 in total

1.  T lymphocyte response to H-2 mutants: cytotoxic effectors are Ly-1+2+.

Authors:  P J Wettstein; D W Bailey; L E Mobraaten; J Klein; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Haplotype-specific differences in signaling by transfected class II molecules to a Ly-1+ B-cell clone.

Authors:  G A Bishop; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Idiotypic and anti-idiotypic B-B cell interaction is controlled by major histocompatibility complex-restricted regulation.

Authors:  S Bitoh; S Fujimoto; H Yamamoto
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

4.  Activation-specific interactions among B-lymphocyte plasma membrane proteins.

Authors:  M G Goodman; R L Wolfert
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Bare lymphocyte syndrome. Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function.

Authors:  L T Clement; S Plaeger-Marshall; A Haas; A Saxon; A M Martin
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Abnormal differentiation of immunoregulatory T-lymphocyte subpopulations in the major histocompatibility complex (MHC) class II antigen deficiency syndrome.

Authors:  L T Clement; J V Giorgi; S Plaeger-Marshall; A Haas; E R Stiehm; A M Martin
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

7.  Characterization of responding cells in oxidative mitogen stimulation. III. Presence of I-A- and I-J, E, C-subregion gene products on the surface of required cells.

Authors:  M L Phillips; S W Hill; J W Parker; R L O'Brien; J A Frelinger
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

8.  Macrophage antiviral activity: extrinsic versus intrinsic activity.

Authors:  S A Stohlman; J G Woodward; J A Frelinger
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

9.  Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia sera.

Authors:  P J Wettstein; J G Frelinger; L Hood
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Interleukin 1 can replace the requirement for I-A-positive cells in the proliferation of antigen-primed T cells.

Authors:  S K Durum; R K Gershon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.